Expertise that Delivers Consistently
In the area of oncology-hematology, you need a CRO partner that can rapidly scale and launch your complex clinical trial. You need access to the right sites, personnel, technology and best in class vendors for lab, imaging, etc. We understand drug development is costly and time to market is critical. We share your goals of bringing life-changing treatments to market and recognize that the milestones we manage in your trials are critical. This is especially true with our small and emerging biotechs where completing the next milestone on-time or early can enable them to secure their next round of funding and to continue their development program.
Pharm-Olam created our Oncology-Hematology Center of Excellence (COE) to combine staff expertise with technology, experienced sites and vendors to create a synergistic effect in order to provide increased operational efficiency across all phases. In addition, we further invested in early phase development where Pharm-Olam commonly finds ourselves supporting small pharma and biotechs. Our early phase accelerator, which supports both oncology and hematology oncology, has additional enhancements to expedite start-up capability and study delivery.